These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9744700)

  • 41. A case of recurrent gastrointestinal bleeding and protein-losing gastroenteropathy.
    Herfarth H; Hofstädter F; Feuerbach S; Jürgen Schlitt H; Schölmerich J; Rogler G
    Nat Clin Pract Gastroenterol Hepatol; 2007 May; 4(5):288-93. PubMed ID: 17476211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful treatment with octreotide of spontaneous chylothorax in a premature infant.
    Coulter DM
    J Perinatol; 2004 Mar; 24(3):194-5. PubMed ID: 15044931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sucessful dietetic-therapy in primary intestinal lymphangiectasia and recurrent chylous ascites: a case report].
    Martín CC; García AF; Restrepo JM; Pérez AS
    Nutr Hosp; 2007; 22(6):723-5. PubMed ID: 18051999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases.
    Perlemuter G; Cacoub P; Chaussade S; Wechsler B; Couturier D; Piette JC
    Arthritis Rheum; 1999 Jul; 42(7):1545-9. PubMed ID: 10403284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapy-refractory primary intestinal lymphangiectasis].
    Biermann J; Meinshausen J; Kuhlmann U
    Dtsch Med Wochenschr; 1991 Sep; 116(39):1473-6. PubMed ID: 1914911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effective made of octreotide intravenous administration for malignant gastrointestinal obstruction in terminal cancer patients].
    Tanimura K; Onda S; Mitsunobu M
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1991-3. PubMed ID: 20948271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of a somatostatin analogue in occult gastrointestinal bleeding: a case report.
    Tamagno G; Mioni R; De Carlo E; Maffei P; Rubello D; Sicolo N
    Dig Liver Dis; 2004 Dec; 36(12):843-6. PubMed ID: 15646433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enamel hypoplasia of the primary dentition in a 4-year-old with intestinal lymphangiectasia.
    Arrow P
    Int J Paediatr Dent; 2005 Sep; 15(5):380-4. PubMed ID: 16129004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Continuous subcutaneous octreotide in gastrointestinal cancer patients: pain control and beta-endorphin levels.
    Befon S; Mystakidou K; Lyra M; Tubanakis N; Vlahos L
    Anticancer Res; 2000; 20(5C):4039-46. PubMed ID: 11268498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.
    Mohnike K; Blankenstein O; Pfuetzner A; Pötzsch S; Schober E; Steiner S; Hardy OT; Grimberg A; van Waarde WM
    Horm Res; 2008; 70(1):59-64. PubMed ID: 18493152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Surgical therapy of segmental jejunal, primary intestinal lymphangiectasia].
    Kneist W; Drescher DG; Hansen T; Kreitner KF; Lang H
    Z Gastroenterol; 2013 Jun; 51(6):576-9. PubMed ID: 23229460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Early-onset of primary intestinal lymphangiectasia. A case report and diet treatment].
    Greco F; Piccolo G; Sorge A; Pavone P; Triglia T; Spina M; Sorge G
    Minerva Pediatr; 2003 Dec; 55(6):615-9. PubMed ID: 14676733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Octreotide for malignant bowel obstruction: twenty years after.
    Mercadante S; Porzio G
    Crit Rev Oncol Hematol; 2012 Sep; 83(3):388-92. PubMed ID: 22277783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intestinal lymphangiectasia: a forgotten cause of chronic diarrhea.
    Rodríguez Leal G
    Rev Gastroenterol Mex; 2006; 71(1):55-8. PubMed ID: 17061479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enterocutaneous fistula: are treatments improving?
    Draus JM; Huss SA; Harty NJ; Cheadle WG; Larson GM
    Surgery; 2006 Oct; 140(4):570-6; discussion 576-8. PubMed ID: 17011904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of hypoalbuminemia with the presence and size of pleural effusion in children with pneumonia.
    Prais D; Kuzmenko E; Amir J; Harel L
    Pediatrics; 2008 Mar; 121(3):e533-8. PubMed ID: 18310174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Octreotide in the treatment of thoracic duct injuries.
    Markham KM; Glover JL; Welsh RJ; Lucas RJ; Bendick PJ
    Am Surg; 2000 Dec; 66(12):1165-7. PubMed ID: 11149591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
    Angeli P; Volpin R; Gerunda G; Craighero R; Roner P; Merenda R; Amodio P; Sticca A; Caregaro L; Maffei-Faccioli A; Gatta A
    Hepatology; 1999 Jun; 29(6):1690-7. PubMed ID: 10347109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Profile, Response to Therapy, and Outcome of Children with Primary Intestinal Lymphangiectasia.
    Prasad D; Srivastava A; Tambe A; Yachha SK; Sarma MS; Poddar U
    Dig Dis; 2019; 37(6):458-466. PubMed ID: 31030202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
    Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.